Enter inventor name

Thomas Charles Britton

This inventor holds 31 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Eli Lilly and Company, Athena Neurosciences, Inc., Elan Pharmaceuticals, Inc.. Active years: 1994-2011.

USPTO Granted Patents = 31 (Patent Applications = 1)

% Patents Active = 48.4

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 6.8

ph-index = 9

Forward Citations = 250(Granted Patents)

Company Filing History:

15 out of 4,507

Eli Lilly and Company

patents

3 out of 35

Athena Neurosciences, Inc.

patents

2 out of 202

Elan Pharmaceuticals, Inc.

patents

4. 16 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2011

Loading Chart...

Areas of Expertise:

mGluR3 Antagonists

Beta-Amyloid Peptide

Pharmaceutical Compositions

Glutamate Receptors

Deoxyamino Acid Compounds

Benzimidazolyl Antagonists

Indolyl Antagonists

Cycloalkyl Compounds

Lactam Derivatives

Lactone Compounds

Pyrazolidin-3-One Derivatives

Nucleosides Anomerization

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7932274 - 3-indazolyl-4-pyridylisothiazoles (2011-04-26),

2. 7868014 - 1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mGluR3 antagonists (2011-01-11),

3. 7390801 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2008-06-24),

4. 6951854 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-10-04),

5. 6906056 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-06-14),

6. 6888022 - Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis (2005-05-03),

7. 6861558 - Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis (2005-03-01),

8. 6800651 - Potentiators of glutamate receptors (2004-10-05),

9. 6774125 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2004-08-10),

10. 6683075 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use (2004-01-27),

11. 6667305 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-12-23),

12. 6653303 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-11-25),

13. 6635632 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-10-21),

14. 6632811 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-10-14),

15. 6579867 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-06-17),

Title: The Innovative Journey of Thomas Charles Britton

Introduction: Thomas Charles Britton, a talented inventor hailing from Carmel, IN (US), has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Britton's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time and a solar-powered irrigation system designed to enhance agricultural practices sustainably.

Career Highlights: With a career spanning over two decades, Britton has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on various sectors.

Collaborations: Throughout his career, Britton has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful commercialization of several groundbreaking technologies.

Conclusion: Thomas Charles Britton's relentless passion for innovation and his commitment to pushing the boundaries of technology continue to inspire the next generation of inventors. His remarkable journey serves as a testament to the power of creativity and perseverance in driving positive change in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]